|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Captopril#Adult Indications and Dosage]] |
| {{Captopril}}
| |
| {{CMG}}; {{AE}} {{AM}}
| |
|
| |
|
| ==HOW SUPPLIED==
| | [[Category: Cardiovascular Drugs]] |
| | | [[Category: Drug]] |
| '''12.5 mg tablets''' in bottles of 100 (NDC 60505-0003-6) and 1000 (NDC 60505-0003-9), '''25 mg tablets''' in bottles of 100 (NDC 60505-0004-6) and 1000 (NDC 60505-0004-9), '''50 mg tablets''' in bottles of 100 (NDC 60505-0005-6) and 1000 (NDC 60505-0005-9), and '''100 mg tablets''' in bottles of 100 (NDC 60505-0006-6) and 1000 (NDC 60505-0006-9).
| | [[Category:ACE inhibitors]] |
| | |
| The 12.5 mg tablet is a round, biconvex tablet, coded “APO 003” with a bisect score on one side and a plain face on the other; the 25 mg tablet is a round, biconvex tablet, coded “APO 004” on one side and a quadrisect score on the other; the 50 mg tablet is capsule shaped, biconvex tablet, coded “APO 005” with a bisect score on one side and a plain face on the other; the 100 mg tablet is capsule shaped, biconvex tablet, coded “APO 006” with a bisect score on one side and a plain face on the other.
| |
| | |
| All captopril tablets are white to off-white and may exhibit a slight sulfurous odor.
| |
| | |
| Storage: Do not store above 86°F. Keep bottles tightly closed (protect from moisture).
| |
| | |
| '''APOTEX INC.'''
| |
| | |
| '''CAPTOPRIL TABLETS, USP'''
| |
| | |
| '''12.5 mg, 25 mg, 50 mg AND 100 mg'''<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CAPTOPRIL (CAPTOPRIL ) TABLET CAPTOPRIL TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c0f1ee3-b2b7-a1bc-059a-d65bea6cd0ef | publisher = | date = | accessdate =}}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]] | |
| [[Category:Drugs]] | |